Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase - PubMed (original) (raw)
Comparative Study
. 1994 Jan 21;269(3):1815-20.
Affiliations
- PMID: 8294430
Free article
Comparative Study
Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase
L Gandino et al. J Biol Chem. 1994.
Free article
Abstract
The receptor for hepatocyte growth factor/scatter factor (HGF/SF) is an alpha beta tyrosine kinase of 190 kDa which mediates growth and motility in several cell types. We have previously shown that tyrosine autophosphorylation enhances the receptor kinase activity, while serine phosphorylation by protein kinase C or other Ca(2+)-dependent kinase(s) is inhibitory. We now identify Ser985 as the major phosphorylation site for the protein kinases responsible for such inhibition. Both phorbol esters or Ca2+ ionophore treatment induces phosphorylation of the same tryptic phosphopeptide corresponding to the sequence Leu983-Arg987 located in the juxta-membrane domain of the receptor beta chain. Purified protein kinase C phosphorylates in vitro a synthetic peptide (V14S) including Ser985. Trypsin digestion of the phosphorylated V14S generates a single phosphopeptide comigrating in reverse-phase high performance liquid chromatography with the tryptic peptide phosphorylated in vivo. Phorbol ester treatment of cultured cells inhibits the ligand-induced tyrosine autophosphorylation of the receptor. In vitro, Ser985 phosphorylation inhibits the receptor tyrosine kinase activity on exogenous substrates. Substitution of Ser985 by site-directed mutagenesis results in increased tyrosine phosphorylation of the receptor and abolishes down-modulation by protein kinase C. These data show that phosphorylation of Ser985 is a key mechanism for the negative regulation of HGF/SF receptor.
Similar articles
- Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.
Bardelli A, Ponzetto C, Comoglio PM. Bardelli A, et al. J Biotechnol. 1994 Sep 30;37(2):109-22. doi: 10.1016/0168-1656(94)90002-7. J Biotechnol. 1994. PMID: 7765452 Review. - Phorbol ester stimulates phosphorylation on serine 1327 of the human insulin receptor.
Lewis RE, Volle DJ, Sanderson SD. Lewis RE, et al. J Biol Chem. 1994 Oct 21;269(42):26259-66. J Biol Chem. 1994. PMID: 7929343 - Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding.
Arnold SF, Obourn JD, Jaffe H, Notides AC. Arnold SF, et al. J Steroid Biochem Mol Biol. 1995 Nov;55(2):163-72. doi: 10.1016/0960-0760(95)00177-2. J Steroid Biochem Mol Biol. 1995. PMID: 7495695
Cited by
- Recording and classifying MET receptor mutations in cancers.
Guérin C, Tulasne D. Guérin C, et al. Elife. 2024 Apr 23;13:e92762. doi: 10.7554/eLife.92762. Elife. 2024. PMID: 38652103 Free PMC article. Review. - Akt Is Controlled by Bag5 through a Monoubiquitination to Polyubiquitination Switch.
Bracho-Valdés I, Cervantes-Villagrana RD, Beltrán-Navarro YM, Olguín-Olguín A, Escobar-Islas E, Carretero-Ortega J, Olivares-Reyes JA, Reyes-Cruz G, Gutkind JS, Vázquez-Prado J. Bracho-Valdés I, et al. Int J Mol Sci. 2023 Dec 15;24(24):17531. doi: 10.3390/ijms242417531. Int J Mol Sci. 2023. PMID: 38139359 Free PMC article. - The Role of cMET in Gastric Cancer-A Review of the Literature.
Van Herpe F, Van Cutsem E. Van Herpe F, et al. Cancers (Basel). 2023 Mar 26;15(7):1976. doi: 10.3390/cancers15071976. Cancers (Basel). 2023. PMID: 37046637 Free PMC article. Review. - MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice.
Fernandes M, Hoggard B, Jamme P, Paget S, Truong MJ, Grégoire V, Vinchent A, Descarpentries C, Morabito A, Stanislovas J, Farage E, Meneboo JP, Sebda S, Bouchekioua-Bouzaghou K, Nollet M, Humez S, Perera T, Fromme P, Grumolato L, Figeac M, Copin MC, Tulasne D, Cortot AB, Kermorgant S, Kherrouche Z. Fernandes M, et al. Mol Oncol. 2023 Nov;17(11):2257-2274. doi: 10.1002/1878-0261.13397. Epub 2023 Jul 14. Mol Oncol. 2023. PMID: 36799689 Free PMC article. - The hepatocyte growth factor/mesenchymal epithelial transition factor axis in high-risk pediatric solid tumors and the anti-tumor activity of targeted therapeutic agents.
Grundy M, Narendran A. Grundy M, et al. Front Pediatr. 2022 Aug 10;10:910268. doi: 10.3389/fped.2022.910268. eCollection 2022. Front Pediatr. 2022. PMID: 36034555 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous